The outcomes of complex chains of reactions are hard to predict. Hindsight being 20–20, I can tell you that implementing the prohibition of alcohol in the 1920s-which was intended to reduce corruption and social problems, but actually lead to a rise in organized crime-was a bad idea.
The outcomes of complex chains of reactions are hard to predict. Hindsight being 20–20, I can tell you that implementing the prohibition of alcohol in the 1920s—which was intended to reduce corruption and social problems, but actually lead to a rise in organized crime—was a bad idea.
Kaylynn Chiarello-Ebner
It's just as difficult to guess what kind of domino effect the recent round of job cuts will have on how the industry grows and develops in the near future. But one area that seems particularly vulnerable is the process analytical technology (PAT) movement. Instrument makers have been hard at work developing tools for the online analysis of everything from cleaning verification to blend uniformity. Many tools are just now creating a buzz among manufacturers and are making their debuts on production lines.
But in this world of ever-shrinking payrolls, I can't help but fear an impending, unintended connection between job cuts and the implementation of these tools. For every online instrument, there must be technicians to oversee the equipment, analyze the results, and make decisions about how to proceed with production. Even in the best of times, already overextended quality control departments would be hard-pressed to supply additional PAT specialists for this purpose (or to ask someone to wear yet another hat).
For companies experiencing personnel cutbacks, assigning more staff to each online tool must be nearly impossible. New online tools are getting more and more advanced, and more and more valuable for pharmaceutical production. But if staffs are too limited in numbers, will online instruments go unused?
Clearly, manpower and technology don't just coexist; they're interlocked. The survival of new tools depends upon staffs that have the training, ability, and shear numbers to use them in their processes.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.